Accelerate your Biologic/Biosimilar Program with Altasciences Laboratory Sciences


Your biologic or biosimilar drug development program deserves the best chance of success.  Altasciences has demonstrated expertise and decades of experience in the development of large molecules, from preclinical safety testing to clinical proof of concept, including robust bioanalytical support, project management, and medical writing. 

We have a wide range of large molecule bioanalytical capabilities, using both ligand binding and mass spectrometry platforms :

  • Method development
  • GCP/GLP-compliant biosimilar assay development and validation
  • Sample analysis for PK and immunogenicity/anti-drug antibody (ADA) testing

To know more, please consult: 

Our Q&A Session with Dr. Danielle Salha, Senior Director, Immunology and Immunochemistry, Ligand Binding Assays 

The Altascientist, a scientific journal with detailed discussion of our bioanalytical capabilities (LC-MS/MS and Ligand Binding) 

Contact our experts today for a customized experience.   

Altasciences transforms the traditional outsourcing paradigm by simplifying and streamlining solutions, whether a single study or multiple programs, to offer an integrated/synchronized approach to CRO and CDMO services from lead candidate selection to clinical proof of concept. 

You may also be interested in the following: